Han-chung T. Wu
128 Academia Road
Nankang, TPQ 11529, Taiwan
Nankang, TPQ 11529, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 83 publications
Broadly neutralizing monoclonal antibodies derived from mRNA LNP immunization exhibit potent neutralizing ability against JN.1, KP.3.1.1 and XEC new Omicron variants.
Journal: The Journal of general virology
Published: April 24, 2026
Armored Chimeric Antigen Receptor T-cell Therapy Targets Antigen-Heterogeneous Glioma.
Journal: Cancer research
Published: April 07, 2026
Programmable Nanobody-Targeting Chimeras Enable Intracellular Viral Protein Degradation.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 23, 2026
Engineering CAR T cells to secrete VEGF-neutralizing scFvs enhances antitumor activity against solid tumors.
Journal: Science translational medicine
Published: March 04, 2026
EpCAM activates the ERK-EGR1 signaling axis and promotes TNF-α-induced the progression of anaplastic thyroid cancer.
Journal: Journal of translational medicine
Published: July 16, 2025
Dendritic cell-targeted liposomes for cancer immunotherapy via inhibition of aryl hydrocarbon receptor.
Journal: Journal of nanobiotechnology
Published: June 18, 2025
Multivalent mRNA Vaccine Elicits Broad Protection against SARS-CoV-2 Variants of Concern.
Journal: Vaccines
Published: May 10, 2024
Intracellular domain of epithelial cell adhesion molecule induces Wnt receptor transcription to promote colorectal cancer progression.
Journal: Journal of biomedical science
Published: April 10, 2024
Correction: Development of a Humanized Antibody with High Therapeutic Potential against Dengue Virus Type 2.
Journal: PLoS neglected tropical diseases
Published: March 13, 2024
Correction: Epithelial cell adhesion molecule (EpCAM) regulates HGFR signaling to promote colon cancer progression and metastasis.
Journal: Journal of translational medicine
Published: January 08, 2024
Last Updated: 09/26/2026